Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer
机构:[1]Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China[2]Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China[3]Shanghai Genitourinary Cancer Institute, Shanghai, China[4]Division of Medical Sciences, National Cancer Centre Singapore, Singapore[5]Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan[6]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[7]Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China[8]Department of Surgery, and SH Ho Urology Center, Chinese University of Hong Kong, Hong Kong, Hong Kong[9]Department of Urology, Nagoya University Graduate School of Medicine, Aichi, Japan[10]Department of Head and Neck and Thoracic Cancers, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore[11]Oncology Academic Programme, Duke-NUS Medical School, Singapore
第一作者机构:[1]Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China[2]Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China[3]Shanghai Genitourinary Cancer Institute, Shanghai, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China[2]Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China[3]Shanghai Genitourinary Cancer Institute, Shanghai, China[*1]Department of Urology, Fudan University Shanghai Cancer Center, 270 Dong’an Road, Shanghai 200032, China.
推荐引用方式(GB/T 7714):
Tingwei Zhang,Yu Wei,Boon Hao Hong,et al.Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer[J].CLINICAL AND TRANSLATIONAL MEDICINE.2023,13(9):doi:10.1002/ctm2.1411.
APA:
Tingwei Zhang,Yu Wei,Boon Hao Hong,Takayuki Sumiyoshi,Enya Hui Wen Ong...&Yao Zhu.(2023).Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.CLINICAL AND TRANSLATIONAL MEDICINE,13,(9)
MLA:
Tingwei Zhang,et al."Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer".CLINICAL AND TRANSLATIONAL MEDICINE 13..9(2023)